Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

AFHSB Case Definition for Breast Cancer: Diagnosis and Surveillance, Lecture notes of Radiotherapy

The case definition for breast cancer developed by the Armed Forces Health Surveillance Branch (AFHSB) for epidemiological reports on invasive breast cancer among active duty Service members. clinical description, background information, case definition rules, and ICD-9 and ICD-10 codes for breast cancer and related treatment procedures.

Typology: Lecture notes

2021/2022

Uploaded on 09/27/2022

theeconomist1
theeconomist1 🇺🇸

4.1

(30)

245 documents

1 / 6

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
1 ONC 14
AFHSB Surveillance Case Definitions
FINAL August 2019
BREAST CANCER
Includes Invasive Cancers Only; Does Not Include Ductal Carcinoma In Situ (DCIS),
Lobular Carcinoma In Situ (LCIS) and Male Breast Cancer
Background
This case definition was developed by the Armed Forces Health Surveillance Branch (AFHSB) for the
purpose of descriptive epidemiological reports on invasive cancers among active duty Service
members.
1
Clinical Description
Breast cancer forms in the tissues of the breast, most commonly in the ducts and lobules. After skin
cancer, breast cancer is the most common type of cancer among women in the United States and the
second leading cause of cancer deaths (after lung cancer). When the breast cancer tumor is small and is
producing no symptoms, the prospects for successful treatment and cure are highest. For this reason,
early detection through mammography is strongly recommended. A family history of breast cancer and
the presence of certain genetic mutations carry an increased risk, but most women who develop breast
cancer have neither of these factors. Other risk factors for breast cancer include advancing age,
overweight or obesity, use of menopausal hormone therapy, physical inactivity, and alcohol
consumption. Treatment of breast cancer may involve surgery, radiotherapy, chemotherapy, and
hormone therapy.
2
1
Armed Forces Health Surveillance Center. Incident diagnoses of cancers and cancer-related deaths,
active component, U.S. Armed Forces, 2005-2014. Medical Surveillance Monthly Report (MSMR).
2016 July; 23(7): 23-31.
2
American Cancer Society. Cancer Facts & Figures 2019. Atlanta: American Cancer Society; 2019.
https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-
2019.html. Accessed July 2019.
Case Definition and Incidence Rules
For surveillance purposes, a case of breast cancer is defined as:
One hospitalization with a case defining diagnosis of breast cancer (see ICD9 and
ICD10 code lists below) in the first diagnostic position; or
One hospitalization with a V or Z-code indicating a radiotherapy, chemotherapy, or
immunotherapy treatment procedure (see ICD9 and ICD10 code lists below) in the first
diagnostic position; AND any case defining diagnosis of breast cancer (see ICD9 and
ICD10 code lists below) in the second diagnostic position; or
Three or more outpatient medical encounters, occurring within a 90-day period, with
any case defining diagnoses of breast cancer (see ICD9 and ICD10 code lists below) in
the first or second diagnostic position.
Incidence rules:
For individuals who meet the case definition: (continued on next page)
pf3
pf4
pf5

Partial preview of the text

Download AFHSB Case Definition for Breast Cancer: Diagnosis and Surveillance and more Lecture notes Radiotherapy in PDF only on Docsity!

AFHSB Surveillance Case Definitions

BREAST CANCER

Includes Invasive Cancers Only; Does Not Include Ductal Carcinoma In Situ (DCIS),

Lobular Carcinoma In Situ (LCIS) and Male Breast Cancer

Background

This case definition was developed by the Armed Forces Health Surveillance Branch (AFHSB) for the

purpose of descriptive epidemiological reports on invasive cancers among active duty Service

members.^1

Clinical Description

Breast cancer forms in the tissues of the breast, most commonly in the ducts and lobules. After skin

cancer, breast cancer is the most common type of cancer among women in the United States and the

second leading cause of cancer deaths (after lung cancer). When the breast cancer tumor is small and is

producing no symptoms, the prospects for successful treatment and cure are highest. For this reason,

early detection through mammography is strongly recommended. A family history of breast cancer and

the presence of certain genetic mutations carry an increased risk, but most women who develop breast

cancer have neither of these factors. Other risk factors for breast cancer include advancing age,

overweight or obesity, use of menopausal hormone therapy, physical inactivity, and alcohol

consumption. Treatment of breast cancer may involve surgery, radiotherapy, chemotherapy, and

hormone therapy.^2

1 Armed Forces Health Surveillance Center. Incident diagnoses of cancers and cancer-related deaths,

active component, U.S. Armed Forces, 2005-2014. Medical Surveillance Monthly Report (MSMR).

2016 July; 23(7): 23-31.

2 American Cancer Society. Cancer Facts & Figures 2019. Atlanta: American Cancer Society; 2019.

https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-

2019.html. Accessed July 2019.

Case Definition and Incidence Rules

For surveillance purposes, a case of breast cancer is defined as:

 One hospitalization with a case defining diagnosis of breast cancer (see ICD9 and

ICD10 code lists below) in the first diagnostic position; or

 One hospitalization with a V or Z-code indicating a radiotherapy, chemotherapy, or

immunotherapy treatment procedure (see ICD9 and ICD10 code lists below) in the first

diagnostic position; AND any case defining diagnosis of breast cancer (see ICD9 and

ICD10 code lists below) in the second diagnostic position; or

 Three or more outpatient medical encounters , occurring within a 90-day period , with

any case defining diagnoses of breast cancer (see ICD9 and ICD10 code lists below) in

the first or second diagnostic position.

Incidence rules:

For individuals who meet the case definition:

(continued on next page)

AFHSB Surveillance Case Definitions

Codes

The following ICD9 and ICD10 codes are included in the case definition:

Condition ICD-10-CM Codes ICD-9-CM Codes

Breast cancer C50 (malignant neoplasm of breast) 174 (malignant neoplasm of female breast) C50.01 (malignant neoplasm of nipple and areola, female)

1. 174.0 (malignant neoplasm of nipple and

areola, female breast)

  • C50.011 (malignant neoplasm of nipple and areola, right female breast)
  • C50.012 (malignant neoplasm of nipple and areola, left female breast)
  • C50.019 (malignant neoplasm of nipple and areola, unspecified female breast) C50.11 (malignant neoplasm of central portion of breast, female)

2. 174.1 (malignant neoplasm of central

portion of female breast)

  • C50.111 (malignant neoplasm of central portion of right female breast)
  • C50.112 (malignant neoplasm of central portion of left female breast)
  • C50.119 (malignant neoplasm of central portion of unspecified female breast) C50.21 (malignant neoplasm of upper-inner quadrant of breast, female)

3. 174.2 (malignant neoplasm of upper-inner

quadrant) (continued on next page)

  • C50.211 (malignant neoplasm of upper- inner quadrant of right female breast)
  • C50.212 (malignant neoplasm of upper- inner quadrant of left female breast)

Case Definition and Incidence Rules (continued)

 The incidence date is considered the date of the first hospitalization or the first of the

three or more outpatient medical encounters occurring within a 90-day period that

includes a case defining diagnosis of breast cancer (see Case Definition and Incidence

Rule Rationale ).

 An individual is considered an incident case only once per lifetime.

Exclusions:

 None

AFHSB Surveillance Case Definitions

  • C50.812 (malignant neoplasm of overlapping sites of left female breast)
  • C50.819 (malignant neoplasm of overlapping sites of unspecified female breast) C50.91 (malignant neoplasm of breast of unspecified site, female)

9. 174.9 (malignant neoplasm of breast,

female, unspecified)

  • C50.9 11 (malignant neoplasm of unspecified site of right female breast)
  • C50.9 12 (malignant neoplasm of unspecified site of left female breast)
  • C50.919 (malignant neoplasm of unspecified site of unspecified female breast)

Procedures ICD-10-CM Codes ICD-9-CM Codes

Related treatment procedures (Radiotherapy, chemotherapy, immunotherapy) Z51.0 (encounter for antineoplastic radiation therapy) V58.0 (radiotherapy) Z51/1 (encounter for antineoplastic chemotherapy and immunotherapy) V58.1 (encounter for chemotherapy and immunotherapy for neoplastic conditions)

  • Z51.11 (encounter for antineoplastic chemotherapy) V58.11 (encounter for antineoplastic chemotherapy)
  • Z51.12 (encounter for antineoplastic immunotherapy) V58.12 (encounter for antineoplastic immunotherapy)

Development and Revisions

 In September of 2015 the case definition was updated to include ICD10 codes.

 This case definition was developed in 2010 by the Armed Forces Health Surveillance Center

(AFHSC) in collaboration with a working group of subject matter experts from the Office of the

Assistant Secretary of Defense for Health Affairs (ASDHA), the United States Army Public

Health Command (USAPHC) and the United States Military Cancer Institute. The case definition

was developed based on reviews of the ICD9 codes, the scientific literature, and previous AFHSC

analyses.

 This case definition was developed for a report on ten different invasive cancers. As such, the

same case finding criteria are used for all types of cancer in the report. This broad application of a

single case definition may affect the sensitivity and specificity in varying ways for the individual

cancers. Furthermore, surgical treatment procedures such as hysterectomy, mastectomy,

prostatectomy, and other procedures unique to certain types of cancer are not included in the code

sets for individual cancers.

AFHSB Surveillance Case Definitions

Case Definition and Incidence Rule Rationale

 This case definition is designed to capture cases of invasive female breast cancer only. Codes

ICD9 233.0 (carcinoma in situ of breast and genitourinary system) / ICD10 D05.90 (unspecified

type of carcinoma in situ of unspecified breast) which includes ductal carcinoma in situ (DCIS)

and lobular carcinoma in situ (LCIS) are not included in the code set. Carcinoma in situ represents

approximately 20% of new breast cancer cases and has different prognoses and treatments than

invasive breast cancer.^2 Because DCIS and LCIS can progress to invasive cancer, women with

these diagnoses should be carefully monitored for progression.^2

 Case finding criteria for this definition requires one hospitalization record with a case-defining

ICD9 or ICD10 code for breast cancer in the first diagnostic position unless a code for a related

treatment procedure is in the first diagnostic position; then the case-defining ICD9 or ICD10 code

for breast cancer is allowed in the second diagnostic position.

 The case finding criterion of three or more outpatient medical encounters, within a 90-day period,

with a case defining diagnosis of breast cancer is used to identify cases that do not meet the other

criteria in the definition. For outpatient encounters, the incident date is considered the first of the

three encounters occurring within the 90-day period (e.g., if a woman has four breast cancer codes

on 1 Jan 12, 1 Dec 15, 8 Dec 15, and 15 Dec 15, the incident date would be 1 Dec 15. 1 Jan 12

would be considered a screening encounter and dropped). Exploratory analysis of the Defense

Medical Surveillance System (DMSS) data revealed that this criterion yielded optimal specificity.^3

The period of 90 days was established to allow for the likelihood that “true” cases of breast cancer

would have second and third encounters within that interval.

 For the purposes of counting new incident cases, AFHSB uses a once per lifetime incidence rule

unless a specific timeframe is more appropriate and is specified (e.g., individuals may be counted

as an incident case once every 365 days). Historically, a "once per surveillance period" incidence

rule was used due to limited data in the Defense Medical Surveillance System (DMSS), but that is

no longer necessary.

Reports

AFHSB reports on female breast cancer in the following reports:

 Periodic MSMR articles on cancers and cancer-related deaths.

Review

Aug 2019 Case definition reviewed and updated by the AFHSB Surveillance Methods and

Standards (SMS) working group.

Sep 2015 Case definition reviewed and updated by the AFHSC Surveillance Methods and

Standards (SMS) working group.

Dec 2012 Case definition reviewed and adopted by the AFHSC Surveillance Methods and

Standards (SMS) working group.

Jun 2012 Case definition reviewed and adopted by the AFHSC MSMR staff.

3 Detailed information on this analysis is available through AFHSB MSMR staff; reference DMSS

Requests #R080127, #R080159, #R090184, #R090302, #R090341, #R100181, and #R100303 (DoD

Cancer Incidence), 2008-2009.